Innovation in the prognostication of chronic lymphocytic leukemia: how far beyond TP53 gene analysis can we go?

Samankaltaisia teoksia

• Prognostic relevance of MYD88 mutations in CLL: the jury is still out
  Tekijä: Baliakas, Panagiotis, et al.
  Julkaistu: (2015)
• ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—update on methodological approaches and results interpretation
  Tekijä: Malcikova, J., et al.
  Julkaistu: (2018)
• Comparative analysis of targeted next-generation sequencing panels for the detection of gene mutations in chronic lymphocytic leukemia: an ERIC multi-center study
  Tekijä: Sutton, Lesley-Ann, et al.
  Julkaistu: (2020)
• Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting
  Tekijä: Sutton, Lesley-Ann, et al.
  Julkaistu: (2015)
• TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics
  Tekijä: Campo, Elias, et al.
  Julkaistu: (2018)